Brazil · Brazilian Health Regulatory Agency · Medical devices
Review target
320 days
regulation
Legal time limit
-
Not published
Steps
5
9 requirements
Application fee
R$39,048
Fee table in force when checked (2026-10-03)
High and maximum risk devices (classes III and IV) need registration after a technical review of the dossier. Approval also waits for an Anvisa GMP certificate. The response targets are 250 days for equipment and software and 320 days for medical materials. Registration lasts 10 years. Medical devices in class III or IV, including devices that contain a medicinal substance with an ancillary action, which are class IV.
The official review target is 320 days (regulation). Time the applicant takes to answer questions (clock stops) is not counted. Targets are not actual review times.
The registration fee, large diagnostic or therapy equipment (for example mri, ct, nuclear medicine) is R$39,048 for Fee table in force when checked (2026-10-03). A reduced fee of R$3,905 applies in some cases (Amount for the largest companies (annual revenue above 50 million reais). Lower amounts by size: 15 percent off for large group II, 30 percent off for medium group III, 60 percent off for medium group IV, 90 percent off for small and 95 percent off for micro companies. Reduced amount shown: small company. Micro companies pay 1,952.40).
1. File registration and pay fee; 2. Technical review; 3. Additional documents requested (clock stopped); 4. GMP certificate published; 5. Registration published.
Outcome: Registration published in the Official Gazette, valid for 10 years and renewable. Valid for 10 years.
Legal basis: Lei 6.360/1976 (Art. 12 and Art. 25); Anvisa RDC 751/2022
Each box is one step; arrows show the order. Dashed boxes happen only in some cases; the orange arrows go back (for example after questions).
About 320 days end to end with the official step targets. Targets, not actual times.
From the official approvals data of this market, all products of this pathway type and segment
In order, with the official target for each step
What the applicant must provide or meet
Targets, not actual review times
| Decisionregulation. Equipment and medical software registrations. | 250 days |
| Review targetregulation. Medical materials. The target for equipment and software is 250 days. Targets are official response times, not observed times. | 320 days |
Official amounts in the local currency
| Fee | Amount |
|---|---|
| Registration fee, large diagnostic or therapy equipment (for example MRI, CT, nuclear medicine)Application · Fee table in force when checked (2026-10-03) · Amount for the largest companies (annual revenue above 50 million reais). Lower amounts by size: 15 percent off for large group II, 30 percent off for medium group III, 60 percent off for medium group IV, 90 percent off for small and 95 percent off for micro companies. Reduced amount shown: small company. Micro companies pay 1,952.40. | R$39,048reduced R$3,905 |
| Registration fee, medium and small equipment, materials, IVDs and other health productsApplication · Fee table in force when checked (2026-10-03) · Amount for the largest companies (annual revenue above 50 million reais). Lower amounts by size: 15 percent off for large group II, 30 percent off for medium group III, 60 percent off for medium group IV, 90 percent off for small and 95 percent off for micro companies. Reduced amount shown: small company. Micro companies pay 780.96. | R$15,619reduced R$1,562 |
Other routes in Brazil: Registration of a new medicine, Registration of an innovative medicine, Good manufacturing practice certification (CBPF), Notification of a class I or II medical device, Optimized analysis for class III and IV devices approved abroad, Software as a medical device (notification or registration). See all routes on the Brazil page or explore them in the Regulatory section.
Not legal or regulatory advice. Check the current official rules before you act. This summary was checked against the official laws, regulations and regulator guidance on October 3, 2026 (26 facts checked). Parts of the approvals data are official open data reused under open licences. Data sources.